Cumberland Pharmaceuticals (CPIX) Change in Inventory (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Change in Inventory of -$703861.0 for Q1 2026, down 441.7% sequentially from $205989.0 in Q4 2025, and up 27.24% YoY from -$553167.6 in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Change in Inventory (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Change in Inventory for 17 years, with the latest figure at -$703861.0 in Q1 2026.
- Quarterly Change in Inventory rose 27.24% year-over-year to -$703861.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.0 million (up 38.26% YoY) and the FY2025 annual result came in at -$2.2 million, up 6.88% from the prior year.
- Change in Inventory eased to -$703861.0 in Q1 2026 per CPIX's latest filing, from $205989.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $1.6 million in Q3 2022 and troughed at -$2.3 million in Q1 2022.
- A 5-year average of -$367224.1 and a median of -$630409.0 in 2025 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2022 and 2024: Change in Inventory jumped 756.09% in 2022, then sank 1073.11% in 2024.
- Over 5 years, Change in Inventory stood at $427803.0 in 2022, then rose by 3.2% to $441498.0 in 2023, then tumbled by 402.63% to -$1.3 million in 2024, then jumped by 115.42% to $205989.0 in 2025, then plunged by 441.7% to -$703861.0 in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered -$703861.0, $205989.0, and -$630409.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 116.71 Mn | 112.84 Mn | - | 703,861.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 703,861.00 |
| Jun 30, 2026 | 703,861.00 |
| Mar 31, 2026 | -703,861.00 |
| Mar 31, 2026 | -703,861.00 |
| Dec 31, 2025 | 205,989.00 |
| Dec 31, 2025 | 205,989.00 |
| Sep 30, 2025 | -630,409.00 |
| Sep 30, 2025 | -630,409.00 |
| Jun 30, 2025 | -850,797.00 |
| Jun 30, 2025 | -850,797.00 |
| Mar 31, 2025 | -967,399.00 |
| Mar 31, 2025 | -967,399.00 |
| Dec 31, 2024 | -1.34 Mn |
| Dec 31, 2024 | -1.34 Mn |
| Sep 30, 2024 | 170,950.00 |
| Sep 30, 2024 | 170,950.00 |
| Jun 30, 2024 | -1.07 Mn |
| Jun 30, 2024 | -1.07 Mn |
| Mar 31, 2024 | -170,469.00 |
| Mar 31, 2024 | -170,469.00 |